Félicité D. C.
- Country
- France
- Department
- Médecine Interne
Research Overview
Data & Insights
Has run more than one trial at 0 of 39 partner sites.
Specializations
Hematologic Malignancies
The investigator addresses aggressive and high‑risk blood cancers, emphasizing genetic‑driven subtypes such as acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome and rare entities like blastic plasmacytoid dendritic cell neoplasm.
- Acute Myeloid Leukemia
- Chronic Myeloid Leukemia (Accelerated Phase)
- Myelodysplastic Syndrome (MDS‑EB2)
- Blastic Plasmacytoid Dendritic Cell Neoplasm
These efforts support precision‑medicine strategies for marrow‑derived malignancies.
Lymphoid and Plasma Cell Disorders
Research focuses on lymphoid and plasma cell diseases, including acute lymphoblastic leukemia, Philadelphia‑positive B‑ALL and multiple myeloma, targeting both frontline and relapsed settings.
- Acute Lymphoblastic Leukemia (B‑cell)
- Philadelphia‑Positive B‑ALL
- Multiple Myeloma
- Relapsed/Refractory Myeloma
Therapeutic advances aim to improve depth of remission and durability.
Solid Tumor Oncology
In solid tumors the investigator explores non‑small cell lung cancer, colon carcinoma, primary brain malignancies such as glioblastoma and complications like brain metastases with radionecrosis.
- Non‑Small Cell Lung Cancer
- Colon Carcinoma
- Glioblastoma
- Brain Metastases (Radionecrosis)
Focus is on integrating immunotherapy and targeted agents with conventional regimens.
Transplantation and Immune Modulation
The investigator’s work on allogeneic hematopoietic stem cell transplantation includes strategies to prevent graft‑versus‑host disease and to manage post‑transplant complications such as pure red cell aplasia.
- Allogeneic Hematopoietic Stem Cell Transplantation
- Graft‑Versus‑Host Disease Prophylaxis
- Post‑Transplant Pure Red Cell Aplasia
Research seeks to balance graft immunity with tolerance.
Infectious and Thrombotic Complications
Efforts target opportunistic infections and coagulation disorders in cancer patients, including chronic pulmonary aspergillosis, cancer‑associated thrombosis, Mycobacterium avium complex lung disease and prevention of Clostridioides difficile infection.
- Chronic Pulmonary Aspergillosis
- Cancer‑Associated Thrombosis
- Mycobacterium avium Complex Lung Disease
- Clostridioides difficile Infection
These studies aim to reduce morbidity in immunocompromised patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.